Virginia Contract Research Organization Co., Ltd.

VCRO  was founded in Taiwan in 1997 and expanded to China and the United States. It took the clinical research of new drugs in the United States, China and Taiwan as its professional service core. In recent years, it has achieved outstanding achievements in regenerative medicines and gene therapy. It is the most professional and experienced CRO in the Asia-Pacific region.

FDA 推動臨床試驗創新

FDA 推動臨床試驗創新

美國食品藥品監督管理局(FDA)致力於推…
Read More
喜躍生醫5月提異體細胞臺腦性麻痺臨床試驗、年底 IPO

喜躍生醫5月提異體細胞臺腦性麻痺臨床試驗、年底 IPO

維州協助客戶遞交臨床一/二期試驗申請。在…
Read More
狂賀!協助病毒載體基因治療應用於視網膜病變疾病治療領域成功獲得 US FDA 同意第 I/II 期臨床試驗執行
What we do

Service Scope

VCRO has been in the market for 27 years, providing a complete one-stop service from IND to NDA. From medical affairs, regulatory affairs, clinical operations, data management and statistics, to EDC remote electronic data capture systems and IWRS, VCRO supports a complete service structure with more than 600 case experience and has delivered 53+ US FDA IND and 98+ GCP audits.

53+ US FDA IND

Cell therapy, CAR-T, LBP, Gene therapy, nucleic acid drugs , miRNA , NCE , 505b2……

Full Service Capacity

Full-service capability

VCRO is extremely confident that we can customize the scope of services for you based on your needs and achieve project success.

0+

Medical Field

+

Clinical Trial

0+

US FDA IND

+

GCP Inspection

News / Events

Breaking News